The Conversation (0)
SeaSpine Announces Fourth Quarter and Full-Year 2017 Results and Issues 2018 Financial Guidance
Mar. 01, 2018 09:22AM PST
Medical Device InvestingSeaSpine (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended December 31, 2017 and provided guidance for 2018. As quoted in the press release: Revenue of $34.0 million, an increase of 4.5% year-over-year U.S. revenue of $31.2 million, …
SeaSpine (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended December 31, 2017 and provided guidance for 2018.
As quoted in the press release:
- Revenue of $34.0 million, an increase of 4.5% year-over-year
- U.S. revenue of $31.2 million, an increase of 4.8% year-over-year
º U.S. Orthobiologics revenue of $16.6 million, an increase of 10.1% year-over-year
º U.S. Spinal Implants revenue of $14.6 million, essentially unchanged year-over-year- International revenue of $2.8 million, an increase of approximately 1% year-over-year
